BPC-157 vs The Wolverine Stack: Research Comparison
A Side-By-Side Research Comparison Of BPC-157 And The Wolverine Stack - single BPC-157 versus the combined BPC-157 and TB-500 blend in recovery research. This Reference Compares Mechanism, Evidence Tier, Molecular Identity, And Pharmacokinetics For Qualified Researchers. For In Vitro Laboratory Research Use Only. Not Medical Advice Or Dosing Guidance.
Side-By-Side Comparison
| BPC-157 | The Wolverine Stack | |
|---|---|---|
| Category | Healing & Recovery | Peptide Stacks |
| Compound Class | Synthetic pentadecapeptide derived from human gastric juice protein BPC | Peptide stack (BPC-157 + Thymosin Beta-4) |
| Evidence Tier | Research Compound | Research Compound |
| Molecular Target | NO-synthase, VEGF, FAK/paxillin, EGF receptor, growth hormone receptor; promotes angiogenesis, collagen synthesis, and cytoprotection | Dual-pathway: BPC-157 via NO/VEGF/EGF; TB-500 via actin-G sequestration and VEGF upregulation |
| Molecular Weight | 1419.5 Da | combination |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | BPC-157 + Thymosin beta-4 fragment |
| CAS Number | 137525-51-0 | n/a |
| Half-Life | ~30 minutes | ~30 minutes (BPC-157) / ~30 hours (TB-500) |
| Studied For | GI mucosal healing, Tendon / ligament repair, Nerve repair, Anti-inflammatory | Soft-tissue repair research, Combined healing and regeneration, Tendon repair acceleration, Ligament healing |
About BPC-157
A popular research healing peptide with strong rodent data but very limited human evidence.
Read The Full BPC-157 MonographAbout The Wolverine Stack
The common repair stack pairing BPC-157 with TB-500; preclinical, and banned in sport via TB-500.
Read The Full The Wolverine Stack MonographKey Differences
- BPC-157 is categorized under Healing & Recovery, while The Wolverine Stack falls under Peptide Stacks.
- Reported half-life differs: BPC-157 at ~30 minutes versus The Wolverine Stack at ~30 minutes (BPC-157) / ~30 hours (TB-500).
- Primary molecular target differs: BPC-157 acts on NO-synthase, VEGF, FAK/paxillin, EGF receptor, growth hormone receptor; promotes angiogenesis, collagen synthesis, and cytoprotection; The Wolverine Stack acts on Dual-pathway: BPC-157 via NO/VEGF/EGF; TB-500 via actin-G sequestration and VEGF upregulation.
Continue Researching
BPC-157 · The Wolverine Stack · Compare Tool · Research Library
This Comparison Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption, Diagnosis, Or Treatment. See The Full Research Disclaimer.